Standpoint Research Upgrades Quest Diagnostics (DGX) to Buy
Tweet
Share
E-mailGet Alerts DGX Hot Sheet
Price: $203.86 +3.39%
Rating Summary:
15 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 7 | New: 32
Rating Summary:
15 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 7 | New: 32
Join SI Premium – FREE
Standpoint Research upgraded Quest Diagnostics (NYSE: DGX) from Hold to Buy with a price target of $60.00.
The firm states, "We closed out DGX with a 19% gain in January. The holding period was three months and we beat the S&P by 900 bps with the low beta name in a rising market. The shares have come back down to where they were when the original recommendation was made. The shares are once again attractive at 10X and can be reinstated."
For more ratings news on Quest Diagnostics click here and for the rating history of Quest Diagnostics click here.
Shares of Quest Diagnostics closed at $46.21 yesterday.
The firm states, "We closed out DGX with a 19% gain in January. The holding period was three months and we beat the S&P by 900 bps with the low beta name in a rising market. The shares have come back down to where they were when the original recommendation was made. The shares are once again attractive at 10X and can be reinstated."
For more ratings news on Quest Diagnostics click here and for the rating history of Quest Diagnostics click here.
Shares of Quest Diagnostics closed at $46.21 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Upgrades Telecom Argentina (TEO) to Overweight
- Axis Capital Limited Upgrades LTM Ltd (LTM:IN) to Buy (1)
- KeyBanc Upgrades Nucor (NUE) to Overweight
Create E-mail Alert Related Categories
UpgradesRelated Entities
Standpoint ResearchSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
